聚乙二醇洛塞那肽临床应用专家共识

2021-12-30 中国药学会医院药学专业委员会 中国医院药学杂志

2015-2017年中华医学会内分泌学分会在全国31个省进行甲状腺、碘营养状态和糖尿病的流行病学调查显示,我国18岁及以上人群糖尿病患病率为11.2%,其中2型糖尿病患者人数占比达90%以上。

中文标题:

聚乙二醇洛塞那肽临床应用专家共识

发布日期:

2021-12-30

简要介绍:

2015-2017年中华医学会内分泌学分会在全国31个省(区、市)进行甲状腺、碘营养状态和糖尿病的流行病学调查显示,我国18岁及以上人群糖尿病患病率为11.2%,其中2型糖尿病(type 2 diabetes mellitus,T2DM)患者人数占比达90%以上[1-2]。然而,目前我国糖尿病患者血糖达标率尚不足50%[1],采用更合理的治疗方案十分必要。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=聚乙二醇洛塞那肽临床应用专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=79c151c00231a476, title=聚乙二醇洛塞那肽临床应用专家共识, enTitle=, guiderFrom=中国医院药学杂志, authorId=0, author=, summary=2015-2017年中华医学会内分泌学分会在全国31个省进行甲状腺、碘营养状态和糖尿病的流行病学调查显示,我国18岁及以上人群糖尿病患病率为11.2%,其中2型糖尿病患者人数占比达90%以上。, cover=https://img.medsci.cn/202218/1641641569829_5579292.png, journalId=0, articlesId=null, associationId=2119, associationName=中国药学会医院药学专业委员会, associationIntro=中国药学会医院药学专业委员会, copyright=0, guiderPublishedTime=Thu Dec 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2015-2017年中华医学会内分泌学分会在全国31个省(区、市)进行甲状腺、碘营养状态和糖尿病的流行病学调查显示,我国18岁及以上人群糖尿病患病率为11.2%,其中2型糖尿病(type 2 diabetes mellitus,T2DM)患者人数占比达90%以上</span><sup style="color: #333333;">[1-2]</sup><span style="color: #333333;">。然而,目前我国糖尿病患者血糖达标率尚不足50%</span><sup style="color: #333333;">[1]</sup><span style="color: #333333;">,采用更合理的治疗方案十分必要。&nbsp;</span></p>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=121080, tagName=聚乙二醇洛塞那肽)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=92353, appHits=53, showAppHits=0, pcHits=552, showPcHits=92300, likes=0, shares=5, comments=2, approvalStatus=1, publishedTime=Sat Jan 08 19:28:03 CST 2022, publishedTimeString=2021-12-30, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Jan 08 19:33:41 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 14:01:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=聚乙二醇洛塞那肽临床应用专家共识.pdf)])
聚乙二醇洛塞那肽临床应用专家共识.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1219064, encodeId=b63a1219064a5, content=学习学习再学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:42:02 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202120, encodeId=2ad61202120e8, content=周制剂依从性更好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/5785b262ac614e2787c8b09e8d8ae840/5cf1162cd10d42bc817ae4b32662d7f8.jpg, createdBy=c27d4938136, createdName=小小的丁香花, createdTime=Sat Mar 12 22:48:27 CST 2022, time=2022-03-12, status=1, ipAttribution=)]
    2022-05-12 湘雅科教

    学习学习再学习!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1219064, encodeId=b63a1219064a5, content=学习学习再学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:42:02 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202120, encodeId=2ad61202120e8, content=周制剂依从性更好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/5785b262ac614e2787c8b09e8d8ae840/5cf1162cd10d42bc817ae4b32662d7f8.jpg, createdBy=c27d4938136, createdName=小小的丁香花, createdTime=Sat Mar 12 22:48:27 CST 2022, time=2022-03-12, status=1, ipAttribution=)]
    2022-03-12 小小的丁香花

    周制剂依从性更好

    0

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA(POA)糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 (2010年)

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01